Assignee
SHANGHAI BAO PHARMACEUTICALS CO LTD
CN·1 granted patent·9 pending applications·0 citations·filing 2020–2025
Top patents by PatentIndex Score
10 records- 0178US12319942B2Use of mutant of immunoglobulin degrading enzyme IdeESHANGHAI BAO PHARMACEUTICALS CO LTD·Filed 2024·Granted Jun 3, 2025·0 cites·14 claims
- 0260US2025257346A1Use of mutant of immunoglobulin degrading enzyme ideeSHANGHAI BAO PHARMACEUTICALS CO LTD·Filed 2025·Application pending·0 cites
- 0356US2025145730A1Anti-immunoglobulin degrading enzyme-digested fc variantSHANGHAI BAO PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0456US2025043026A1Fc polypeptide having altered glycosylation modificationSHANGHAI BAO PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0554US2025099557A1Antibiotic pharmaceutical composition capable of subcutaneous administrationSHANGHAI BAO PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0653US2025361498A1Mutants of immunoglobulin-degrading enzyme ideeSHANGHAI BAO PHARMACEUTICALS CO LTD·Filed 2025·Application pending·0 cites
- 0751US2023277633A1Pharmaceutical composition of enzymes and viruses and application thereofSHANGHAI BAO PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 0850US2023364207A1Mutant of immunoglobulin degrading enzyme ideeSHANGHAI BAO PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 0949US2023374083A1Pharmaceutical combination and use thereofSHANGHAI BAO PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 1044US2022143178A1Anti-her2 bispecific antibody and application thereofSHANGHAI BAO PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHANGHAI BAO PHARMACEUTICALS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →